Innovative Medicines Canada (IMC) and a number of pharmaceutical companies have jointly commenced an application for judicial review of the … read more »
The Department of Health and Social Care (DHSC) has published information on the 2019 Voluntary Scheme for Branded Medicines Pricing … read more »
AIFA’s 1.83% payback is a provision whereby pharmaceutical companies are charged an amount based on the retail price of medicinal … read more »
The Ministry of Enterprise and Innovation has Sweden has released the English version of its national life sciences strategy. The … read more »
A milestone was hit in the COVID-19 vaccination campaign this morning, as a 90-year-old became the first person in the … read more »
The Câmara de Regulação do Mercado de Medicamentos (CMED) has authorised the maximum commercial prices for the medicines Zolgensma and … read more »
Dozens of UK hospital hubs will begin vaccinating the most vulnerable people against COVID-19 this week, in the largest NHS … read more »
NICE has announced the winner of this year’s Shared Learning Awards as Avon and Wiltshire Mental Health Partnership, for a … read more »
In the first digital general meeting of the Federal Association of the Pharmaceutical Industry (BPI), Dr. Hans-Georg Feldmeier has been … read more »
In order to standardise the price increase procedure for medical products classified in band C with prescription, which can only … read more »
MAP BioPharma Limited
Upper Pendrill Court
Ermine Street North
Papworth Everard
Cambridge
CB23 3UY
United Kingdom
MAP BioPharma Limited No: 08209281
Phone: +44 1480 832360
Email: enquiries@mapbiopharma.com
or use the Contact Form
Please also visit our partner site:
